| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | $6.1B | $4.8B | — | — |
| Cost of Revenue | $3.6B | $3.0B | $2.3B | $1.5B |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | $-0.0B | $-0.6B | $-0.8B | $-1.5B |
| Net Income | $0.0B | $-0.5B | $-0.8B | $-1.4B |
| EPS (Basic) | $0.01 | $-1.05 | $-1.73 | $-3.16 |
| EPS (Diluted) | $-0.01 | $-1.05 | $-1.73 | $-3.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $4.5B | $4.3B | $3.9B | $4.0B |
| Current Assets | $1.8B | $1.5B | $2.1B | $2.1B |
| Cash & Equivalents | $1.1B | $0.8B | $1.3B | $1.3B |
| Total Liabilities | $3.9B | $3.3B | $3.1B | $2.7B |
| Current Liabilities | $1.8B | $1.7B | $1.5B | $1.2B |
| Stockholders' Equity | $0.6B | $1.0B | $0.8B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.4B | $-0.0B | $-0.6B |
| Investing Cash Flow | $-0.2B | $-0.6B | $-0.1B | $-0.2B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.1B | $-0.1B | $-0.0B |